e-learning
resources
Madrid 2019
Monday, 30.09.2019
Tuberculosis: diagnosis
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Lung microRNAs as biomarkers of post primary TB variants.
G. Shepelkova (Moscow, Russian Federation), V. Evstifeev (Moscow, Russian Federation), A. Ergesheva (Moscow, Russian Federation), A. Guskov (Moscow, Russian Federation), M. Bagirov (Moscow, Russian Federation), V. Yeremeev (Moscow, Russian Federation)
Source:
International Congress 2019 – Tuberculosis: diagnosis
Session:
Tuberculosis: diagnosis
Session type:
Thematic Poster
Number:
3012
Disease area:
Respiratory infections
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
G. Shepelkova (Moscow, Russian Federation), V. Evstifeev (Moscow, Russian Federation), A. Ergesheva (Moscow, Russian Federation), A. Guskov (Moscow, Russian Federation), M. Bagirov (Moscow, Russian Federation), V. Yeremeev (Moscow, Russian Federation). Lung microRNAs as biomarkers of post primary TB variants.. 3012
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Andi Muh Aunul Khaliq Gunawan - 24.04.2022 05:27
Can we get full text from this research ?
You must
Login
to comment this presentation.
Related content which might interest you:
Expert interview: TB-Machine learning and artificial intelligence as allies in clinical decision
Debate -Tuberculosis: Rolling out of new drugs without diagnostic capacities
Panel discussion on unprecedented progress in shortening treatment for TB: Evidence to date, and future possibilities
Related content which might interest you:
Lung cancer biomarkers based on miRNA
Source: Virtual Congress 2021 – Biology of lung cancer: preclinical and translational research
Year: 2021
MicroRNAs in serum of post primary TB patients.
Source: International Congress 2018 – The immune response to tuberculosis: development of biomarkers and diagnostic tools
Year: 2018
Metabolomic profiling of clinical sputum samples reveals novel biomarkers for the early identification of lung cancer patients
Source: International Congress 2014 – Improving diagnosis of thoracic tumours
Year: 2014
Determining genomic rearrangements in clinical lung specimens for assessment of metastatic disease, actionable targets and disease monitoring
Source: International Congress 2016 – New genomic targets in pulmonary disease
Year: 2016
mRNA biomarker screening in pulmonary tumors showing neuroendocrine differentiation
Source: Annual Congress 2013 –Prognostic factors and subtyping of lung cancer
Year: 2013
Differential microRNA expression in plasma of patients with pulmonary tuberculosis
Source: International Congress 2015 – Latest news on miRNAs in pulmonary research
Year: 2015
The utility of bronchoscopically acquired tissue for successful lung cancer molecular profiling (LC-MP)
Source: Annual Congress 2013 –Comfort, safety and effectiveness of bronchoscopy
Year: 2013
Circulating biomarkers and tumour molecular profiling in patients with non-small cell lung cancer
Source: International Congress 2015 – Biomarkers, immunology and molecular pathology of lung cancer
Year: 2015
Exploring the 24h-effect of targeted therapies in non-small cell lung cancer from exon array blood profiling using dually constrained correspondence analysis
Source: International Congress 2015 – Lung cancer: prognostic factors and features of oncogene-driven tumours
Year: 2015
Metabolomic signature in COPD. Plasma and lung tissue comparison identify sphingolipids as potential biomakers
Source: International Congress 2014 – Markers
Year: 2014
Identifying a tissue specific microRNA molecular signature in lung cancer
Source: Virtual Congress 2021 – Biology of lung cancer: preclinical and translational research
Year: 2021
Micro-RNA screening in neuroendocrine lung tumors: Differential expression of miR-29 family members
Source: Annual Congress 2013 –New strategies in epigenomic research to study lung diseases (DNA rearrangements, RNA, methylation, proteosome)
Year: 2013
Which gene expression signatures in pharmacogenomic strategies for lung cancer?
Source: Annual Congress 2010 - Customised chemotherapy for lung cancer
Year: 2010
Novel biomarker more strongly associated with tuberculosis treatment outcome than conventional or genotypic methods
Source: International Congress 2015 – Science and biomarkers in TB
Year: 2015
LATE-BREAKING ABSTRACT: Genome-wide association studies identify novel loci associated with early postnatal lung function
Source: International Congress 2015 – Genetics and environmental factors in phenotypes of asthma and COPD
Year: 2015
Potential genetic markers for the early diagnosis of peripheral and metastatic lung cancer
Source: International Congress 2015 – Cell biology of lung cancer and new biomarkers
Year: 2015
Cancer-associated oncogenic BARD1 isoforms: From biomarker expression studies to development of a blood test for early detection of lung cancer
Source: Annual Congress 2012 - Early detection of lung cancer
Year: 2012
Early detection of lung cancer in exhaled breath condensate using miRNA markers
Source: International Congress 2015 – Developments in lung cancer diagnosis
Year: 2015
Validation of a gene-based lung cancer risk test (Respiragene) for high risk smokers: A targeted approach to early detection of lung cancer
Source: Annual Congress 2010 - Lung cancer, idiopathic pulmonary fibrosis and sarcoidosis: the genetic approach
Year: 2010
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept